Expert Panel: Speeding through the Process of Securing Investment into Treg-Directed Therapies, the Story of GentiBio

Time: 8:30 am
day: Day Two


  • Discussing examples of investment from an academic, industry and VC perspective and sharing what could have been done better
  • Where are the field’s blind spots which challenge future progress?
  • What should academia (as an engine of scientific discovery) and their funders focus on to ensure Treg-directed therapies reach the patients that could benefit?